hla class II DR DQ antigen associ idiopath cardiomyopathi valid studi meta-analysi hla associ studi antigen frequenc differ idiopath cardiomyopathi idc patient healthi control pilot studi find independ studi prospect hypothesi frequenc second famili class II hla-dq proxim DQ loci DR loci strong linkag disequilibrium DR DQ allel new consecut seri idc patient healthi blood bank control increas antigen frequenc patient trend decreas express patient patient control patient control rel risk etiolog fraction combin haplotyp caucasian idc patient none control comparison specif antigen frequenc preliminari valid studi signific differ data studi combin combin studi control control rel risk etiolog fraction 